These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37582053)

  • 41. Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis.
    Tyzack GE; Luisier R; Taha DM; Neeves J; Modic M; Mitchell JS; Meyer I; Greensmith L; Newcombe J; Ule J; Luscombe NM; Patani R
    Brain; 2019 Sep; 142(9):2572-2580. PubMed ID: 31368485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The occurrence of mutations in FUS in a Belgian cohort of patients with familial ALS.
    Damme PV; Goris A; Race V; Hersmus N; Dubois B; Bosch LV; Matthijs G; Robberecht W
    Eur J Neurol; 2010 May; 17(5):754-6. PubMed ID: 19922450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fus gene mutations in familial and sporadic amyotrophic lateral sclerosis.
    Rademakers R; Stewart H; Dejesus-Hernandez M; Krieger C; Graff-Radford N; Fabros M; Briemberg H; Cashman N; Eisen A; Mackenzie IR
    Muscle Nerve; 2010 Aug; 42(2):170-6. PubMed ID: 20544928
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening of SOD1, FUS and TARDBP genes in patients with amyotrophic lateral sclerosis in central-southern China.
    Hou L; Jiao B; Xiao T; Zhou L; Zhou Z; Du J; Yan X; Wang J; Tang B; Shen L
    Sci Rep; 2016 Sep; 6():32478. PubMed ID: 27604643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The FUS protein: Physiological functions and a role in amyotrophic lateral sclerosis].
    Efimova AD; Ovchinnikov RK; Roman AY; Maltsev AV; Grigoriev VV; Kovrazhkina EA; Skvortsova VI
    Mol Biol (Mosk); 2017; 51(3):387-399. PubMed ID: 28707655
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in Amyotrophic Lateral Sclerosis.
    Wang H; Guo W; Mitra J; Hegde PM; Vandoorne T; Eckelmann BJ; Mitra S; Tomkinson AE; Van Den Bosch L; Hegde ML
    Nat Commun; 2018 Sep; 9(1):3683. PubMed ID: 30206235
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Astrocytes expressing ALS-linked mutant FUS induce motor neuron death through release of tumor necrosis factor-alpha.
    Kia A; McAvoy K; Krishnamurthy K; Trotti D; Pasinelli P
    Glia; 2018 May; 66(5):1016-1033. PubMed ID: 29380416
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update.
    Lattante S; Rouleau GA; Kabashi E
    Hum Mutat; 2013 Jun; 34(6):812-26. PubMed ID: 23559573
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis.
    Pokrishevsky E; Grad LI; Yousefi M; Wang J; Mackenzie IR; Cashman NR
    PLoS One; 2012; 7(4):e35050. PubMed ID: 22493728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative proteomics identifies proteins that resist translational repression and become dysregulated in ALS-FUS.
    Baron DM; Matheny T; Lin YC; Leszyk JD; Kenna K; Gall KV; Santos DP; Tischbein M; Funes S; Hayward LJ; Kiskinis E; Landers JE; Parker R; Shaffer SA; Bosco DA
    Hum Mol Genet; 2019 Jul; 28(13):2143-2160. PubMed ID: 30806671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuronal dysfunction caused by FUSR521G promotes ALS-associated phenotypes that are attenuated by NF-κB inhibition.
    Pelaez MC; Desmeules A; Gelon PA; Glasson B; Marcadet L; Rodgers A; Phaneuf D; Pozzi S; Dutchak PA; Julien JP; Sephton CF
    Acta Neuropathol Commun; 2023 Nov; 11(1):182. PubMed ID: 37974279
    [TBL] [Abstract][Full Text] [Related]  

  • 52. From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis.
    Alrafiah AR
    In Vivo; 2018; 32(5):983-998. PubMed ID: 30150420
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Upregulation of β-catenin due to loss of miR-139 contributes to motor neuron death in amyotrophic lateral sclerosis.
    Hawkins S; Namboori SC; Tariq A; Blaker C; Flaxman C; Dey NS; Henley P; Randall A; Rosa A; Stanton LW; Bhinge A
    Stem Cell Reports; 2022 Jul; 17(7):1650-1665. PubMed ID: 35750046
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ALS-linked FUS exerts a gain of toxic function involving aberrant p38 MAPK activation.
    Sama RR; Fallini C; Gatto R; McKeon JE; Song Y; Rotunno MS; Penaranda S; Abdurakhmanov I; Landers JE; Morfini G; Brady ST; Bosco DA
    Sci Rep; 2017 Mar; 7(1):115. PubMed ID: 28273913
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules.
    Bosco DA; Lemay N; Ko HK; Zhou H; Burke C; Kwiatkowski TJ; Sapp P; McKenna-Yasek D; Brown RH; Hayward LJ
    Hum Mol Genet; 2010 Nov; 19(21):4160-75. PubMed ID: 20699327
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antiviral Immune Response as a Trigger of FUS Proteinopathy in Amyotrophic Lateral Sclerosis.
    Shelkovnikova TA; An H; Skelt L; Tregoning JS; Humphreys IR; Buchman VL
    Cell Rep; 2019 Dec; 29(13):4496-4508.e4. PubMed ID: 31875556
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Loss and gain of FUS function impair neuromuscular synaptic transmission in a genetic model of ALS.
    Armstrong GA; Drapeau P
    Hum Mol Genet; 2013 Nov; 22(21):4282-92. PubMed ID: 23771027
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Screening of the FUS gene in familial and sporadic amyotrophic lateral sclerosis patients of Chinese origin.
    Zou ZY; Peng Y; Feng XH; Wang XN; Sun Q; Liu MS; Li XG; Cui LY
    Eur J Neurol; 2012 Jul; 19(7):977-83. PubMed ID: 22340366
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis.
    Scekic-Zahirovic J; Oussini HE; Mersmann S; Drenner K; Wagner M; Sun Y; Allmeroth K; Dieterlé S; Sinniger J; Dirrig-Grosch S; René F; Dormann D; Haass C; Ludolph AC; Lagier-Tourenne C; Storkebaum E; Dupuis L
    Acta Neuropathol; 2017 Jun; 133(6):887-906. PubMed ID: 28243725
    [TBL] [Abstract][Full Text] [Related]  

  • 60. RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations.
    Daigle JG; Lanson NA; Smith RB; Casci I; Maltare A; Monaghan J; Nichols CD; Kryndushkin D; Shewmaker F; Pandey UB
    Hum Mol Genet; 2013 Mar; 22(6):1193-205. PubMed ID: 23257289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.